Immune checkpoint expression in head and neck cancer

被引：0
|
作者：
Puntigam, L. [1 ]
Jeske, S. [1 ]
Brunner, C. [2 ]
Hoffmann, T. [3 ]
Schuler, P. [2 ]
机构：
[1] Univ Klin Ulm, Kopf Hals Tumorzentrum Ulm, Klin Hals Nasen Ohrenheilkunde & Kopf Hals Chirur, Ulm, Germany
[2] Univ Klin Ulm, Klin Hals Nasen Ohrenheilkunde & Kopf Hals Chirur, Ulm, Germany
[3] Univ Klin Ulm, Klin Hals Nasen Ohrenheilkunde Kopf & Halschirurg, Klin Hals Nasen Ohrenheilkunde, Ulm, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
609
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [21] The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors
    Rusz, Orsolya
    Pal, Margit
    Szilagyi, Eva
    Rovo, Laszlo
    Varga, Zoltan
    Tomisa, Bernadett
    Fabian, Gabriella
    Kovacs, Levente
    Nagy, Olga
    Mozes, Petra
    Reisz, Zita
    Tiszlavicz, Laszlo
    Deak, Peter
    Kahan, Zsuzsanna
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (02) : 253 - 264
  • [22] Impact of salvage chemotherapy after immune checkpoint inhibitor for recurrent or metastatic head and neck cancer
    Matoba, Takuma
    Minohara, Kiyoshi
    Kawakita, Daisuke
    Sawabe, Michi
    Takano, Gaku
    Oguri, Keisuke
    Murashima, Akihiro
    Iwaki, Sho
    Tsuge, Hiroshi
    Imaizumi, Sae
    Hojo, Wataru
    Kondo, Ayano
    Tsukamoto, Koji
    Iwasaki, Shinichi
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (08): : 1855 - 1864
  • [23] Adverse jaw outcomes from immune checkpoint inhibitors for head and neck cancer? Case reports
    Subramanian, Gayathri
    Yeung, Vincent
    Baredes, Soly
    Kim, Sung
    Bergsbaken, Tessa
    Quek, Samuel Y. P.
    QUINTESSENCE INTERNATIONAL, 2024, 55 (03): : 244 - 249
  • [24] Statin Drugs Are Associated With Response to Immune Checkpoint Blockade in Recurrent/Metastatic Head and Neck Cancer
    Kristoff, Tyler J.
    Evans, Sean
    Nayi, Pranay
    Abousaud, Marin
    Goyal, Subir
    Liu, Yuan
    Shin, Dong
    Steuer, Conor E.
    Saba, Nabil F.
    Schmitt, Nicole C.
    CANCER MEDICINE, 2025, 14 (05):
  • [25] Cold atmospheric plasma sensitizes head and neck cancer to chemotherapy and immune checkpoint blockade therapy
    Wang, Yanhong
    Mang, Xinyu
    Li, Danni
    Wang, Zhao
    Chen, Yiliang
    Cai, Zhenyu
    Tan, Fei
    REDOX BIOLOGY, 2024, 69
  • [26] Immune Checkpoint Inhibitors Serve as the First-Line Treatment for Advanced Head and Neck Cancer
    Huang, Yan
    Zhou, Hong
    Zhao, Guangyong
    Wang, Meihua
    Luo, Judong
    Liu, Jun
    LARYNGOSCOPE, 2024, 134 (02): : 749 - 761
  • [27] Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer
    Zhao, Ye
    Wucherpfennig, Kai W.
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (03) : 136 - 142
  • [28] Immune checkpoint blockade provokes resident memory T cells to eliminate head and neck cancer
    Veatch, Joshua R.
    Riddel, Stanley R.
    CELL, 2022, 185 (16) : 2848 - 2849
  • [29] Novel drugs including immune checkpoint inhibitors in combination with radiation therapy for head and neck cancer
    Akimoto, Tetsuo
    ANNALS OF ONCOLOGY, 2021, 32 : S256 - S256
  • [30] Immune landscape in Head and Neck cancer
    Brandau, S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 6 - 6
12345